Clinical Trials

Showing trials with last updates posted in 2026.

NCT03939897 | ACTIVE_NOT_RECRUITING | PHASE1
24 participants

Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-18
Start Date:
2020-06-17
Completion:
2023-06-22
Conditions
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Breast Carcinoma
  • Metastatic HER2-Negative Breast Carcinoma
  • Metastatic Hormone Receptor-Positive Breast Carcinoma
  • Recurrent Breast Carcinoma
Interventions
  • DRUG
  • PROCEDURE
NCT03728361 | COMPLETED | PHASE2
55 participants

Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-18
Start Date:
2018-12-31
Completion:
2025-12-02
Conditions
  • Grade I Neuroendocrine Carcinoma
  • Grade II Neuroendocrine Carcinoma
  • Grade III Neuroendocrine Carcinoma
  • Metastatic Neuroendocrine Carcinoma
  • Neuroendocrine Carcinoma
  • Recurrent Small Cell Lung Carcinoma
  • Refractory Small Cell Lung Carcinoma
  • Lung Cancer Stage IV
  • Large Cell Neuroendocrine Carcinoma
  • Neuroendocrine Tumors
  • Small Cell Lung Cancer Metastatic
  • Small-cell Lung Cancer
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT03367741 | ACTIVE_NOT_RECRUITING | PHASE2
82 participants

Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-18
Start Date:
2018-04-16
Completion:
2025-05-09
Conditions
  • Advanced Endometrial Carcinoma
  • Metastatic Endometrial Carcinoma
  • Recurrent Endometrial Carcinoma
  • Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
  • Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
NCT03365908 | ENROLLING_BY_INVITATION | NA
60 participants

Pain Management of ACL Reconstruction

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-18
Start Date:
2017-10-09
Completion:
2027-07-01
Conditions
  • Anterior Cruciate Ligament Rupture
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT03235531 | TERMINATED | PHASE4
3 participants

Assessment of Valproate on Ethanol Withdrawal

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-18
Start Date:
2017-07-11
Completion:
2019-06-25
Conditions
  • Alcohol Dependence
  • Alcohol Withdrawal Syndrome
  • Trauma
  • Heavy Drinking
  • Alcohol Use Disorder
Interventions
  • DRUG
No Results Yet
NCT03198026 | ACTIVE_NOT_RECRUITING | PHASE2
29 participants

Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-18
Start Date:
2018-02-20
Completion:
2023-10-24
Conditions
  • Non-Hodgkin's Lymphoma
  • Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • Ann Arbor Stage II Follicular Lymphoma
  • Ann Arbor Stage II Nodal Marginal Zone Lymphoma
  • Ann Abor Stage III B-Cell Non-Hodgkin Lymphoma
  • Ann Arbor Stage III Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • Ann Arbor Stage III Follicular Lymphoma
  • Ann Arbor Stage III Nodal Marginal Zone Lymphoma
  • Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma
  • Ann Arbor Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • Ann Arbor Stage IV Follicular Lymphoma
  • Ann Arbor Stage IV Nodal Marginal Zone Lymphoma
  • Grade 1 Follicular Lymphoma
  • Grade 2 Follicular Lymphoma
  • Grade 3a Follicular Lymphoma
  • Indolent Non-hodgkin Lymphoma
  • Stage II Splenic Marginal Zone Lymphoma
  • Stage III Splenic Marginal Zone Lymphoma
  • Stage IV Splenic Marginal Zone Lymphoma
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
NCT03096054 | COMPLETED | PHASE1
69 participants

A Phase I Trial of LY3143921 Hydrate in Solid Tumours

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-18
Start Date:
2017-06-21
Completion:
2025-04-09
Conditions
  • Colorectal Cancer
  • High Grade Serous Ovarian Cancer
  • Non Small-cell Lung Cancer (Squamous Cell Variant)
  • Urothelial Cancer
  • Breast Cancer (Triple Negative Type)
  • Pancreatic Cancer
  • Squamous Carcinoma of the Head and Neck (Human Papillomavirus (HPV) Negative)
Interventions
  • DRUG
No Results Yet
NCT02243605 | ACTIVE_NOT_RECRUITING | PHASE2
90 participants

Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-18
Start Date:
2014-12-19
Completion:
2019-06-30
Conditions
  • Metastatic Ewing Sarcoma
  • Metastatic Osteosarcoma
  • Recurrent Ewing Sarcoma
  • Recurrent Osteosarcoma
  • Stage III Osteosarcoma AJCC v7
  • Stage IV Osteosarcoma AJCC v7
  • Stage IVA Osteosarcoma AJCC v7
  • Stage IVB Osteosarcoma AJCC v7
  • Unresectable Ewing Sarcoma
  • Unresectable Osteosarcoma
Interventions
  • DRUG
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page